Notifications for Medical and Pharmaceutical Professionals
Documents
- 19.03.2021: Information for Medical Doctors - COVID-19 Vaccine AstraZeneca
- 18.02.2021: Risk Evaluation for Potential Nitrosamine Impurities for National Authorised Medicines for Human Use in the Competence of the Paul-Ehrlich-Institut (Update February 2021)
- 01.02.2021: Public Consultation: Draft Joint Announcement by BfArM and Paul-Ehrlich-Institut for the Follow-up of Spontaneous Reports of Suspected Cases of Adverse Effects pursuant to Section 63c AMG
- 23.12.2020: Recommendation on Corona Vaccination for Allergic Persons
- 30.04.2020: Notes on Marketing Authorisation Procedures During the COVID-19 Pandemic
- 20.03.2020 Information on the Total Replacement of AMIS
- 10.09.2018: Availability of Test allergens for Rare Allergies - Application for Fee Reduction (German Only)
Updated: 19.03.2021
